Tag: Celleration
BioMedical firm acquires wound device maker
February 4, 2015HME News Staff
LANGHORNE, Pa. - Alliqua BioMedical, a maker of wound care products, has agreed to acquire Eden Prairie-based Celleration for $30.4 million in stock and cash, according to an article in the Philadelphia Business Journal. Celleration is the manufacturer of MIST Therapy, an ultrasound system for treating acute and chronic wounds. Celleration had revenues of about $8.7 million in 2014. The deal will nearly double the size of Alliqua's sales force, said CEO David Johnson in the article.
Alliqua BioMedical, Celleration
Sponsored Stories
How Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office SupportCyber Siege: The Financial Vulnerability Healthcare Didn't See Coming
By Strategic Office SupportA new staffing model that delivers ready-to-work pros, boosting efficiency and lowering costs.
By Tactical Back Office